CompletedNCT01411774
Adding D-Cycloserine to CBT for Childhood OCD
About this title
D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD)
Read the official source — NCT01411774Medication studyAges 7–17United States
Understand this study
Who was this study for?
Listed age limits: 7 years to 17 years.
- Listed locations
- St. Petersburg and 1 more locationSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateJune 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 142
- Sponsor
- University of South Florida
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 7 Years to 17 Years
- Official registry ID
- NCT01411774
- Official title
Show the full official title
1/2 D-cycloserine Augmentation of CBT for Pediatric OCD
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
St. Petersburg · Cambridge
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of South Florida, a university.
Did this study involve medication?
Yes. The study involved medication, including d-cycloserine and Pill placebo.
Who was this study for?
Listed age limits: 7 years to 17 years.
